Francois Carbonnel - Amgen Insider

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

Independent Director

Mr. Francois de Carbonnel is an Independent Director of Amgen Inc. Franois de Carbonnel is a director of corporations and corporate advisor. Mr. de Carbonnel was a member of the group governance council of Mazars Group, a privatelyheld international organization specializing in audit, accountancy, tax, legal and advisory services, from December 2011 to January 2016. From 2004 to May 2015, Mr. de Carbonnel was a director of Solocal Group, a French company which offers online content, advertising solutions and transactional services, and served as Chairman of the Remuneration and Appointments Committee. From 2004 until October 2013, Mr. de Carbonnel was a director of a number of funds managed by Ecofin, a privatelyheld investment management firm. Mr. de Carbonnel was a director of Thomson S.A., a French multimedia corporation, from 2007 to January 2010, serving as Chairman of the Audit Committee throughout his tenure, and as nonexecutive Chairman of the Board from April 2008 to April 2009. Mr. de Carbonnel was a director of Quilvest S.A., a Luxembourg company which provides wealth management and private equity services, from 2006 to 2013.
Age: 69  Director Since 2008      
805-447-1000  http://www.amgen.com

Management Efficiency

The company has return on total asset (ROA) of 8.32 % which means that it generated profit of $8.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 7.18 % meaning that it created $7.18 on every $100 dollars invested by stockholders.
The company currently holds 35.34 B in liabilities with Debt to Equity (D/E) ratio of 140.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

William SpenglerEndo International plc
2008
Phebe NovakovicAbbott Laboratories
2010
Douglas IngramEndo International plc
2016
Peter McDonnellAllergan plc
2015
James FarrellAbbott Laboratories
2006
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
David AltshulerVertex Pharmaceuticals Incorpor
2015
Michael GallagherAllergan plc
2015
Patrick OSullivanAllergan plc
2013
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Ron TaylorAllergan plc
2013
Daniel StarksAbbott Laboratories
2017
Michael HyattEndo International plc
N/A
Arthur HigginsEndo International plc
2013
Roxanne AustinAbbott Laboratories
2000
Robert MalchioneBio Rad Laboratories Inc
2014
Nancy HutsonEndo International plc
2009
Shane CookeEndo International plc
2014
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Alan GarberVertex Pharmaceuticals Incorpor
2017
Samuel ScottAbbott Laboratories
2007

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Aroon Oscillator Now
   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Hide  View All  NextLaunch Aroon Oscillator
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators